Turkish Journal of Medical Sciences
Volume 30

Number 3

Article 6

1-1-2000

Quantitation of Neuronal Loss Induced by Status Epilepticus and
the Effects of Nitric Oxide
GÜLDAL GÜLEÇ
BEHZAT NOYAN

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
GÜLEÇ, GÜLDAL and NOYAN, BEHZAT (2000) "Quantitation of Neuronal Loss Induced by Status
Epilepticus and the Effects of Nitric Oxide," Turkish Journal of Medical Sciences: Vol. 30: No. 3, Article 6.
Available at: https://journals.tubitak.gov.tr/medical/vol30/iss3/6

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turk J Med Sci
30 (2000) 229–234
© TÜBİTAK

Güldal GÜLEÇ
Behzat NOYAN

Quantitation of Neuronal Loss Induced by Status
Epilepticus and the Effects of Nitric Oxide

Received: June 16, 1999

Abstract: Neuronal loss in the hippocampal
CA1 and CA3 fields due to lithiumpilocarpine-induced status epilepticus (SE)
and the effects of a nitric oxide (NO)
substrate, L-Arginine and a NO synthase
inhibitor, Nw-nitro-L-Arginine methyl ester
(L-NAME) on SE-induced brain damage were
determined using the neuron counting
procedure in rats. Rats were implanted with
four chronic, epidural screw electrodes in
order to obtain electrocortical recordings. SE
was determined from the electrocortical
recordings. After decapitation, the brains
were removed, and the hippocampal sections
were obtained and stained with hematoxylin
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Introduction
Temporal lobe epilepsy (TLE) is a common
neurological disorder which is frequently drug-resistant.
A number of studies have focused on the
pathophysiological mechanisms underlying this disease.
The common neuropathological lesion is hippocampal
sclerosis, characterized by neuronal loss and gliosis in the
hippocampus (1). It has been reported that a severe
convulsion in early childhood may be responsible for the
characteristic neuronal loss in hippocampal sclerosis (2).
The most vulnerable neurons in the hippocampus are CA1
and CA3 pyramidal cells and dentate hilar neurons,
whereas CA2 neurons and dentate gyrus granule cells are
relatively resistant (3).
It has been suggested that the cellular pathology
associated with sustained seizure activity is due to
seizure-mediated release and inefficient reuptake of
excitatory amino acids (EAA), namely glutamate and
aspartate (4). Excessive stimulation of N-methyl-Daspartate (NMDA)-type EAA receptors is related to the
induction and maintenance of the epileptic condition and

and eosin. An analysis of variance (ANOVA)
and Student's t- test were used for statistical
purposes. The normal pyramidal neuron
numbers of rats which had exhibited SE were
significantly lower than those of rats that had
not displayed SE. Both L-Arginine and LNAME increased the neuronal loss induced by
SE. We concluded that lithium-pilocarpineinduced SE leads to neuronal loss in the
hippocampal CA1 and CA3 fields. L-Arginine
and L-NAME, which were expected to show
opposite actions, acted in a similar manner at
the given doses.
Key Words: Lithium-pilocarpine, Status
epilepticus, L-Arginine, L-NAME, Neuron loss.

also epileptic brain damage (5,6). It has been shown that
a noncompetetive NMDA antagonist, ketamine, protects
neurons from status epilepticus (SE)-induced damage (7).
It is now well known that nitric oxide (NO) mediates
some of the physiological and pathological effects of
NMDA receptor stimulation. NO is a free radical gas,
which serves as a neuronal retrograde messenger in the
central nervous system (CNS) (8-10). It is synthesized
from L-Arginine by calcium/calmodulin-dependent NO
synthase in association with the activation of NMDA
receptors (8,10,11). When these receptors are activated,
cytosolic Ca2+ increases due to the influx of large amounts
of Ca2+ through the receptor-associated ion channels; this
Ca2+ combines with calmodulin and activates NO synthase
(12).
The aim of this study was to quantitate the neuronal
loss due to SE induced by systemic injection of pilocarpine
in lithium-pretreated rats and to investigate the effects of
a NO substrate, L-Arginine, and a NO synthase inhibitor,
Nw-nitro-L-Arginine methyl ester (L-NAME), on SEinduced brain damage.
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Material and Methods
Male Wistar albino rats (Uludağ University,
Experimental Animals Breeding and Research Centre,
Bursa, Turkey) weighing 240-340 g were used. The rats
were kept in a temperature-controlled room (18-22 °C)
and were given food and water ad libitum.
Under Thiopental Sodium (Penthotal Sodium-Abott)
anesthesia, the rats were implanted with four chronic,
epidural screw electrodes in order to obtain
electrocortical recordings. The electrodes were implanted
bilaterally over the fronto-parietal cortices (±2 mm
behind the bregma and ±2 mm lateral to the midline) and
an additional electrode on the nasal bone served as a
reference electrode. The rats were allowed to recover
from surgery over seven days. SE was induced by
systemic administration of LiCl (3 mEq/kg, i.p.), which
was followed 24 hours later by a pilocarpine HCl injection
(45 mg/kg, i.p.). L-Arginine (300 mg/kg, i.p.) or L-NAME
(20 mg/kg, i.p.) was given 30 minutes before the
pilocarpine. Each group consisted of 15 rats. All the rats
were observed electrocortically and behaviourally for
three hours after the pilocarpine injection. SE was
determined from electrocortical recordings. In addition,
electrodes were implanted in four rats and these rats
received saline in order to form the sham-control group.
Four other rats were used as naives and none of the
interventions were applied to these rats.
All drugs were purchased from Sigma Chemical Co.,
St Louis. LiCl was dissolved in distilled water; pilocarpine,
L-Arginine and L-NAME were dissolved in saline at a
volume of 0.2 ml.
At the end of the experiments, the rats that had
survived were placed individually in cages and allowed to
live for 12 days. Then they were decapitated, and the
brains were rapidly removed and frozen with CO2 gas.
Because of the high mortality observed in the L-NAMEapplied rats (all rats that underwent SE in this group died
within129±15 minutes after the pilocarpine injection),
these rats were decapitated whenever a consistent flat
line was observed on the electrocorticogram.
To obtain neuron counts from both the anterior and
posterior hippocampus,12 µm coronal cryostat sections
were obtained in the levels corresponding to bregma 2.8
and 5.6 of the Paxinos and Watson (13) atlas. From each
level, two sections were obtained and stained with
hematoxylin and eosin. In each section, undamaged
pyramidal neurons of the hippocampal CA1 and CA3
fields were counted using an ocular grid at a total
magnification of 400x. Only neurons with a visible

230

nucleus and/or a complete cell contour were counted
(14). Neurons touching the upper or left borders were
included and those touching the bottom or right borders
were rejected. For each hippocampal zone, neurons in
five squares with an area of 2300 µm2 were counted
from four independent fields. The cell counts were
corrected by Abercrombie's formula (15) and the average
areal density of neurons in mm2 for each hippocampal
field in each section was then calculated. The neuron
counts from each section in the same level were then
averaged. In addition, since there was no statistically
significant difference in terms of neuron counts between
two hemispheres or between two levels, all the values for
each hippocampal field were averaged for each rat and
these values were used for statistical analysis.

Statistical analysis: For each rat, the neuron numbers
in the anterior and posterior hippocampus and right and
left hemispheres were compared with the Student's t test
(unpaired). Comparisons of the neuron counts of all the
groups, including SE-positive (+) and SE-negative (-) rats,
were performed with an analysis of variance (ANOVA).
Results
The average pyramidal neuron numbers in the
hippocampal CA1 and CA3 fields of the naives, shamcontrol group, control group, L-Arginine group and LNAME group rats are shown in the Table. There was no
statistically significant difference between the neuron
counts of the naives, sham-control group and the control
group SE (-) rats. In the control group, the neuron
numbers in both hippocampal fields in the SE (+) rats
were significantly lower than those in the SE (-) rats
(p<0.001). The pyramidal neurons of the CA1 and CA3
fields were also lost due to SE in both the L-Arginine and
L-NAME groups (p<0.001 for each group).
When compared to the neuron counts of the SE (-)
rats of the control group, the neuron numbers in both
fields of the SE (-) rats in the other two groups did not
differ significantly. On the other hand, the neuron counts
of the SE (+) rats of all the groups significantly decreased
with respect to those of the control group SE (-) rats
(p<0.001). A characteristic view of the neuronal damage
was observed in the light microscopic analysis of the
hippocampi of the SE (+) rats, with acidophilic neurons,
as well as gliosis (Figures 1 and 2).
An interesting result regarding the effects of LArginine and L-NAME was that the neuron loss induced by
SE was significantly greater in both hippocampal fields in
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rats that were treated with either of these drugs
(p<0.001). There was no significant difference between
the L-Arginine and L-NAME groups with regard to the
neuron counts of SE (+) rats.

Discussion
In this study, we induced SE by injection of a low-dose
cholinergic muscarinic agonist, pilocarpine, in LiClpretreated rats. The neuronal damage observed in SE
Table.

Groups
Naives (n=4)
Sham-control group (n=4)
Control group SE (-) (n=3)
Control group SE (+) (n=4)
L-Arginine group SE (-) (n=4)
L-Arginine group SE (+) (n=4)
L-NAME group SE (-) (n=4)
L-NAME group SE (+) (n=4)
*
**
ψ
α
δ
π

p<0.001
p<0.001
p<0.001
p<0.001
p<0.001
p<0.001

Figure 1.

vs
vs
vs
vs
vs
vs

Neuron Numbers
in CA1 Field
(x ± SE / mm2)

Neuron Numbers
in CA3 Field
(x ± SE / mm2)

1097.95 ± 29.01
1208.85 ± 25.74
1092.08 ± 53.90
600.68 ± 46.99 *
1227.57 ± 34.79
185.92 ± 40.51*ψ
1234.04 ± 44.70
130.31 ± 28.67 *δ

706.27 ± 20.78
748.53 ± 15.45
703.00 ± 17.65
426.75 ± 11.61 **
799.36 ± 18.28
192.21 ± 43.79 **α
775.94 ± 25.24
115.13 ± 19.73 **π

The average undamaged
pyramidal neuron numbers in
CA1 and CA3 fields of naives,
sham-control, control, LArginine and L-NAME groups.

control group SE (-) rats for CA1 field.
control group SE (-) rats for CA3 field.
L-Arginine group SE (-) rats for CA1 field.
L-Arginine group SE (-) rats for CA3 field.
L-NAME group SE (-) rats for CA1 field.
L-NAME group SE (-) rats for CA3 field.

The normal appearance of the large pyramidal neurons of the hippocampal CA3 field. Sections were obtained from a normal rat. H&E, x40.
(npn: normal pyramidal neuron).
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Figure 2.

Microphotograph of the CA3 field of a rat that had displayed SE and was sacrificed on the twelfth day. Note the acidophilic neurons and
gliosis. H&E, 40. (a: acidophilic neurons, g: gliosis).

induced by high-dose pilocarpine or lithium-pilocarpine
have been shown to mimic the neuropathological features
of human TLE (16-19). It has been reported that
acetylcholine itself is not neurotoxic, since intraventricular
injection of high doses of acetylcholine does not produce
direct glial or neurotoxic effects, while intraventricular
injections of glutamate and aspartate reproduce the
characteristic morphological changes observed in human
epileptics (5). Secondary activation of glutamatergic and
aspartergic neurons due to hyperstimulation of
cholinoceptive neurons may explain the neuronal damage
observed in cholinergic seizures (4).
In this study, we found no significant difference
concerning the neuron numbers between the naives,
sham control group and control group SE (-) rats.
However, when SE was well established, the pyramidal
neuron numbers were significantly reduced (p<0.001).
This implies that a severe seizure activity is necessary to
induce characteristic neuron loss in this model of epilepsy.
These findings are consistent with quantitative studies
performed in rats (18) and in humans (2).
There have been a number of studies investigating the
role of NO in the pathogenesis of epileptic seizures, but
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the effect of NO on seizure-induced brain damage has not
been widely studied yet. Bagetta et al. (6) reported that
intracerebroventricular microinfusion of L-NAME
significantly reduces the seizures and brain damage
induced by systemic injection of tacrine, an
acetylcholinesterase inhibitor, in LiCl-pretreated rats. In
our study, both L-Arginine and L-NAME significantly
worsened the neuron loss due to lithium-pilocarpineinduced SE. The contradictory results may be due to the
different routes of drug injection.
It is quite interesting that both a NO substrate and a
NO synthase inhibitor increased the neuronal loss induced
by SE, but it is difficult to explain these results. The
dosage of these drugs may be the major point for their
neuroprotective or neurodestructive actions, since NO is
known to exert both of these effects, depending on
several mechanisms. Stimulation of NMDA receptors
results in the formation of both NO and superoxide anions
(20). The interaction of NO with superoxide anions yields
peroxynitrite anions that become protonated to
peroxynitrous acid in aqueous solutions, which
spontaneously decomposes into cytotoxic hydroxyl
radicals (21,22). This may be responsible for the
neurotoxic effects of NO. On the other hand, NO not only
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activates guanylate cyclase and leads to an increase in
cGMP in target cells in response to NMDA receptor
stimulation, but it may also exert a negative feedback
effect on its own synthesis by inhibiting a redox
modulatory site on the NMDA receptor-channel complex
(23,24). Such an inhibitory mechanism may inhibit
excessive stimulation of NMDA receptors and prevent
neurotoxicity. In addition, the antioxidant property of NO

through its interaction with superoxide anions may
account for its neuroprotective effect (25).
As a result, we conclude that SE induced by lithiumpilocarpine leads to significant neuron loss in the
hippocampal CA1 and CA3 fields, which we determined
quantitatively. NO exerts contradictory effects on SEinduced neuron loss in this model of epilepsy, which
should be investigated by further dosage studies.
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